COMBINED CANNABIS/METHAQUALONE WITHDRAWAL TREATED WITH PSYCHOTROPIC ANALGESIC NITROUS OXIDE

REFERENCES

• Alho H., Methuen T., Paloheimo M., Strid N., Seppa K., Tiainen J., Salaspuro M., Roine R. Long-term effects of and physiological responses to nitrous oxide gas treatment during alcohol withdrawal: A double-blind, placebo-controlled trial. Alcoholism: Clinical Experimental Research 2002; 26: 1816–1822, [CSA]
   PubMed Web of Science ®Google Scholar
• Alho H., Metheun T., Paloheimo M., Seppä K., Strid N., Apter-Kaseva N., Tiainen K., Salaspuro M., Roine R. Nitrous oxide has no effect in the treatment of alcohol withdrawal syndrome: Double-blind placebo-controlled randomized trial. Journal of Clinical Psychopharmacology 2003; 23: 211–214, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Carroll M., Gallo G. Methaqualone the quest for oblivion. The encyclopedia of psychoactive drugs, S. H. Snyder, M. Lader. Burke Publishing Company, London 1988a; 15–25
   Google Scholar
• Carroll M., Gallo G. 1988b; pp. 15–25; 81–84, Ibid.http://www.csa.com/htbin/linkabst.cgi?issn=0412-4081&vol=&iss=&[CSA]
   Google Scholar
• Carroll M., Gallo G. 1988c; pp. 51–61, Ibid.[CSA]
   Google Scholar
• Carroll M., Gallo G. 1988d; pp. 63–69, Ibid.[CSA]
   Google Scholar
• Clark M. S., Brunick A. Handbook of Nitrous Oxide and Oxygen Sedation. Mosby, St. Louis 1999
   Google Scholar
• Clark M. S., Campbell S. A., Clark A. M. Technique for the administration of nitrous oxide/oxygen sedation to ensure psychotropic analgesic nitrous oxide (PAN) effects. International Journal of Neuroscience 2006; 116: 871–877, [CSA]
   Web of Science ®Google Scholar
• Daynes G., Gillman M. A. Psychotropic analgesic nitrous oxide prevents craving after withdrawal for alcohol, cannabis and tobacco. International Journal of Neuroscience 1994; 76: 13–16, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Dworkin S. F., Schubert M., Chen A. Cx˙ N., Clark D. W. Psychological preparation influences nitrous oxide analgesia: Replication of laboratory findings in a clinical setting. Oral Surgery Oral Medicine and Oral Pathology 1986; 61: 108–112, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Gillman M. A., Lichtigfeld F. J. Minimal sedation required with nitrous oxide-oxygen treatment of the alcohol withdrawal state. British Journal of Psychiatry 1986; 148: 604–606, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gillman M. A., Lichtigfeld F. J. Analgesic nitrous oxide for alcohol withdrawal: A critical appraisal after 10 years use. Postgraduate Medical Journal 1990; 66: 543–546, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gillman M. A., Lichtigfeld F. J. Placebo and analgesic nitrous oxide for the alcohol withdrawal state. British Journal of Psychiatry 1991a; 159: 672–675, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gillman M. A., Lichtigfeld F. J. The opioid effects of analgesic (subanesthetic) nitrous oxide on the alcohol withdrawal state. Annals of the New York Academy of Sciences 1991b; 625: 784–785, [INFOTRIEVE], [CSA]
   Google Scholar
• Gillman M. A., Lichtigfeld F. J. Clinical role and mechanisms of action of analgesic nitrous oxide. International Journal of Neuroscience 1998; 93: 55–62, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gillman M. A., Lichtigfeld F. J. Randomised double-blind trial of psychotropic analgesic nitrous oxide compared with diazepam for alcohol withdrawal state. Journal of Substance Abuse Treatment 2002; 22: 129–134, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Gillman M. A., Lichtigfeld F. J. Correct use of analgesic nitrous oxide for the alcohol withdrawal state essential. Journal of Clinical Psychopharmacology 2004; 24: 238–239, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Gillman M. A., Lichtigfeld F. J. Psychotropic analgesic nitrous oxide (PAN) as a probe of the endogenous opioid system in man and for treating substance abuse withdrawal. In L. A. Bennet (Ed.). New Topics in Substance Abuse Treatment. Nova Science, New York 2006; pp. 1–72
   Google Scholar
• Gordon D. 1992, Mandrax—the drug and the discourse—a case study of Parkwood. Research Report: Sociology Department, University of Cape Town.[CSA]
   Google Scholar
• Griffiths R. R., Sannerud C. A. Abuse of and dependence on benzodiazepines and other anxiolytic/sedative drugs. Psychopharmacology: The third generation of progress, H. Y. Meltzer. Raven Press, New York 1987; 1535–1541
   Google Scholar
• Gross M., Lewis E., Nagarajan M. An improved quantitative system for assessing the acute alcoholic psychoses and related states (TSA and SSA). Alcohol intoxication and withdrawal: Experimental Studies, Vol. 35, M. Gross. Plenum Press, New York 1973; 35: 365–376
   Google Scholar
• Gross M., Lewis E., Hastey J. Acute alcohol withdrawal syndrome. The biology of alcoholism, Vol. 3, B. Kissin, H. Begleiter. Plenum Press, New York 1974; 3 191–256
   Google Scholar
• Karrassellos C., Wilson B. A South African outpatient drug treatment centre. South African Medical Journal 1993; 83: 337–338, [CSA]
   Google Scholar
• Lichtigfeld F. J., Gillman M. A. The treatment of alcoholic withdrawal states with oxygen and nitrous oxide. South African Medical Journal 1982; 61: 349–351, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lichtigfeld F. J., Gillman M. A. The effect of placebo in the alcohol withdrawal state. Alcohol and Alcoholism 1989a; 24: 109–112, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lichtigfeld F. J., Gillman M. A. Analgesic nitrous oxide for alcohol withdrawal is better than placebo. International Journal of Neuroscience 1989b; 49: 71–74, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lichtigfeld F. J., Gillman M. A. Role of dopamine mesolimbic system in opioid action of psychotropic analgesic nitrous oxide (PAN) in alcohol and drug withdrawal. Clinical Neuropharmacology 1996; 19: 246–250, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Madden J. S. A guide to alcohol and drug dependence. John Wright & Sons, Bristol 1979
   Google Scholar
• McCarthy G., Heiberg L., Smith L. P. Analysis of street mandrax—clinical implications. 8th National Psychiatry Congress, Somerset WestSouth Africa, September, 21–231994
   Google Scholar
• McCarthy G., Myers B. Treatment for mandrax (combination of methaqualone, cannabis and tobacco) dependence in adults (Protocol for a Cochrane Review). In The Cochrane Library, Issue 2. Update Software, Oxford 2003
   Google Scholar
• Ojutkangas R. A case study of opposition to innovation: Pioneering PAN in Finland for withdrawal. International Journal of Neuroscience, in press[CSA]
   Google Scholar
• Ojutkangas R., Gillman M. A. Psychotropic analgesic nitrous oxide for treating alcohol withdrawal in an outpatient setting. International Journal of Neuroscience 1994; 76: 35–39, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Parry C. Dx˙ H., Bhana A., Pluddermann A., Myers B., Siegfried N., Morojelle N. K., Flisher A. J., Kozell N. J. The South African Community Epidemiology Network on Drug Use (SACENDU): Description, findings (1997–1999) and policy implications. Addiction 2002; 97: 969–976, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Pascarelli E. F. Methaqualone abuse, the quiet epidemic. Journal of the American Medical Association 1973; 224: 1512–1514, [INFOTRIEVE], [CROSSREF], [CSA]
   Web of Science ®Google Scholar
• Searll A. It can't happen to me. Struik Publishers, Cape Town 1989; 70–80
   Google Scholar
• Sher M. L. An analysis of a variety of illicit methaqualone formulations and an investigation into the effect of smoking on methaqualone present in these formulations, Honours Thesis accepted in part fulfilment for BSc (Honours) Degree UCT. Cape TownSouth Africa 1993
   Google Scholar
• Sullivan J. T., Sykora K., Schneiderman J., Naranjo C. A., Sellers E. M. Assessment of alcohol withdrawal: The revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). British Journal of Addiction 1989; 84: 1353–1357, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar